Resapp Health Stock

Resapp Health EBIT

The EBIT of Resapp Health (RAP.AX) as of Jun 23, 2026 is -6.95 T AUD.In the previous year, EBIT was -6.77 T AUD — a change of 2.52% (lower).

EBIT

-6.95 TAUD

YoY

2.52%

Last updated:

In 2026, Resapp Health's EBIT was -6.95 T AUD, a 2.52% increase from the -6.77 T AUD EBIT recorded in the previous year.

The Resapp Health EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (k AUD)
Date
EBIT (k AUD)
Jan 1, 2004
-830 base
Jan 1, 2005
-680 base
Jan 1, 2006
-2,150 base
Jan 1, 2007
-3,920 base
Jan 1, 2008
-1,230 base
Jan 1, 2009
-970 base
Jan 1, 2010
210 base
Jan 1, 2011
-390 base
Jan 1, 2012
-830 base
Jan 1, 2013
-920 base
Jan 1, 2014
-470 base
Jan 1, 2015
-488.7 base
Jan 1, 2016
-3,204.9 base
Jan 1, 2017
-10,027.9 base
Jan 1, 2018
-6,529.3 base
YEAREBIT (k AUD)
2025 est -
2024 est -
2023 est -
2022 -6,945.5
2021 -6,774.5
2020 -8,469.2
2019 -5,439.5
2018 -6,529.3
2017 -10,027.9
2016 -3,204.9
2015 -488.7
2014 -470
2013 -920
2012 -830
2011 -390
2010 210
2009 -970
2008 -1,230
2007 -3,920
2006 -2,150
2005 -680
2004 -830
Access this data via the Eulerpool API

Resapp Health Revenue

Resapp Health Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2004
0 AUD
-830,000 AUD
-1.18 M AUD
Jan 1, 2005
200,000 AUD
-680,000 AUD
-710,000 AUD
Jan 1, 2006
420,000 AUD
-2.15 M AUD
-1.82 M AUD
Jan 1, 2007
1.41 M AUD
-3.92 M AUD
-3.67 M AUD
Jan 1, 2008
0 AUD
-1.23 M AUD
-3.59 M AUD
Jan 1, 2009
0 AUD
-970,000 AUD
-1.2 M AUD
Jan 1, 2010
850,000 AUD
210,000 AUD
220,000 AUD
Jan 1, 2011
80,000 AUD
-390,000 AUD
-530,000 AUD
Jan 1, 2012
60,000 AUD
-830,000 AUD
-830,000 AUD
Jan 1, 2013
20,000 AUD
-920,000 AUD
-920,000 AUD
Jan 1, 2014
0 AUD
-470,000 AUD
-580,000 AUD
Jan 1, 2015
173,400 AUD
-488,700 AUD
-489,300 AUD
Jan 1, 2016
82,600 AUD
-3.2 M AUD
-3.21 M AUD
Jan 1, 2017
204,300 AUD
-10.03 M AUD
-10.03 M AUD
Jan 1, 2018
87,000 AUD
-6.53 M AUD
-6.53 M AUD

Resapp Health Margins

Resapp Health stock margins

The Resapp Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Resapp Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Resapp Health.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2004
39.01 %
- %
- %
Jan 1, 2005
15 %
-340 %
-355 %
Jan 1, 2006
64.29 %
-511.9 %
-433.33 %
Jan 1, 2007
39.01 %
-278.01 %
-260.28 %
Jan 1, 2008
39.01 %
- %
- %
Jan 1, 2009
39.01 %
- %
- %
Jan 1, 2010
39.01 %
24.71 %
25.88 %
Jan 1, 2011
39.01 %
-487.5 %
-662.5 %
Jan 1, 2012
39.01 %
-1,383.33 %
-1,383.33 %
Jan 1, 2013
39.01 %
-4,600 %
-4,600 %
Jan 1, 2014
39.01 %
- %
- %
Jan 1, 2015
39.01 %
-281.83 %
-282.18 %
Jan 1, 2016
39.01 %
-3,880.02 %
-3,883.29 %
Jan 1, 2017
39.01 %
-4,908.42 %
-4,910.82 %
Jan 1, 2018
39.01 %
-7,504.94 %
-7,509.66 %

Resapp Health Stock analysis

What does Resapp Health do? ResApp Health Ltd is an Australian company that focuses on the development of digital diagnostic and treatment solutions in the field of respiratory diseases. The company was founded in 2014 by Tony Keating and Philippa Lewis, both of whom have significant experience in the medical technology industry. The company aims to improve and simplify the diagnosis of respiratory diseases by developing a diagnosis based on cough and breath sounds. To achieve this, the company has developed an intelligent system based on machine learning and artificial intelligence that analyzes individual sound waves and provides an accurate diagnostic capability. ResApp Health's business model is based on the development of digital diagnostic and treatment solutions in the field of respiratory diseases, which are offered through various distribution channels. The company offers both mobile apps and clinical diagnostic systems. ResApp Health operates in various divisions at different levels. On the one hand, the company conducts research and development to continuously improve its products. On the other hand, it works closely with clinicians, scientists, and other industry experts to enable the best possible patient treatment. Products offered by ResApp Health include digital diagnostic systems in the field of respiratory diseases that function based on cough and breath sounds. The products are offered for use in both clinical practice and at home to enable fast and accurate diagnosis. Another important area in which ResApp Health operates is the treatment of respiratory diseases. The company offers digital therapy platforms tailored to the individual needs of patients, enabling improved therapy. ResApp Health has already achieved a number of important milestones. For example, in 2016, the company received CE marking for its digital diagnostic system, and in 2017, it completed a clinical study that demonstrated the system's high accuracy in diagnosing respiratory diseases. Overall, ResApp Health has great potential to play an important role in the field of diagnosis and treatment of respiratory diseases in the future. With a strong focus on research and development and close collaboration with industry experts, the company will continue to offer innovative solutions to improve patient health. Resapp Health is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Resapp Health's EBIT

Resapp Health's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Resapp Health's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Resapp Health's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Resapp Health’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Resapp Health stock

EBIT of Resapp Health amounted to -6.77 T AUD -6.95 T

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Resapp Health

All Key Metrics — Resapp Health